Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 29

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 29
---
 directors of Laboratory Corporation of America Holdings, a public clinical laboratory company, and Fortrea, a clinical research organization. He has previously served as a member of the board of directors of several private companies. Mr. Neupert served as a member of the Board of Trustees of Fred Hutchinson Cancer Research Center from June 2007 to June 2020. Mr. Neupert holds an MBA from the Tuck School of Business at Dartmouth College and a BA in Philosophy from Colorado College. We believe Mr. Neupert is qualified to serve on our board of directors based on his extensive experience in leadership roles in the health services sector and as a member of the board of directors of several organizations in the biotechnology industry.**

<div align='center'>20</div>

EXECUTIVE OFFICERS The following table sets forth certain information about our executive officers:

| Name                |     | Age |    |     | Position(s)                               |
| Chad Robins         |     |     | 50 |     | Chief Executive Officer and Chairman      |
| Kyle Piskel         |     |     | 41 |     | Chief Financial Officer                   |
| Sharon Benzeno, PhD |     |     | 51 |     | Chief Commercial Officer, Immune Medicine |
| Susan Bobulsky      |     |     | 44 |     | Chief Commercial Officer, MRD             |
| Francis Lo          |     |     | 44 |     | Chief People Officer                      |
| Harlan Robins, PhD  |     |     | 52 |     | Chief Scientific Officer                  |
| Julie Rubinstein    |     |     | 53 |     | President and Chief Operating Officer     |

The following is a biographical summary of the experience of our current executive officers, with the exception of Mr. Robins, whose biographical summary is set forth under the caption “ Class III Director Nominee Biography.” Kyle Piskelhas served as our Chief Financial Officer since April 2024. He joined us in September 2015 and has served in various roles of increasing levels of responsibility, including as Interim Chief Financial Officer from February 2022 to June 2022 and Principal Accounting Officer since October 2021. Prior to joining us, Mr. Piskel was an Accounting Manager at Expedia Group from October 2014 to August 2015. Prior to joining Expedia Group, Mr. Piskel was in the Assurance services practice at Ernst and Young, LLP from August 2007 to October